Novo Nordisk applies the same procedures wherever we sponsor clinical trials. This means that all participants enrolled in Novo Nordisk trials are protected by the same rights, high ethical standards and regulations irrespective of the location of the study.
Information on Novo Nordisk's approach to ethical issues in relation to clinical trials is compiled at our clinical trials website, a site providing an overview of all Novo Nordisk's clinical trials worldwide.
To provide new insight into the shared value created to key stakeholders in connection with clinical research Novo Nordisk has conducted a BluePrint for Change study on clinical trials ‘Assessing the value of diabetes clinical research’. Our hope is that the study will be a catalyst for discussions about how clinical research can create even more value for all stakeholders involved and society at large.
As a researcher you may want to study the underlying study or patient level data to conduct further research. Read about the possibilities.